Sun SX,Li ZH,Sun L,et al.Results on efficacy and safety of cancer treatment with or without tumor necrosis factor-related apoptosis-inducing ligand-related agents:A meta-analysis[J].Mol Clin Oncol,2014,2(3):440-448.
[2]
Bellail AC,Qi L,Mulligan P,et al.TRAIL agonists on clinical trials for cancer therapy:the promises and the challenges[J].Rev Recent Clin Trials,2009,4(1):34-41.
[3]
Lan Y,Liu XF,Zhang R,et al.Lithium enhances TRAIL-induced apoptosis in human lung carcinoma A549cells[J].Bio Metals,2013,26(2):241-254.
[4]
Wang X,Chen W,Zeng W,et al.Akt-mediated eminent expression of c-FLIP and Mcl-1confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells[J].Mol Cancer Ther,2008,7(5):1 156-1 163.
[5]
Ouyang W,Yang CX,Zhang SM,et al.Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells[J].Int J Oncol,2013,42(2):699-711.
DeSantis CE,Lin C,Mariotto AB,et al.Cancer treatment and survivorship statistics,2014[J].CA Cancer J Clin,2014,64(4):252-271.
[8]
Zhang L,Fang B.Mechanisms of resistance to TRAIL-induced apoptosis in cancer[J].Cancer Gene Ther,2005,12(3):228-237.
[9]
Matsebatlela T,Gallicchio V,Becker R.Lithium modulates cancer cell growth,apoptosis,gene expression and cytokine production in HL-60promyelocytic leukaemia cells and their drug-resistant sub-clones[J].Biol Trace Elem Res,2012,149(3):323-330.
[10]
Johnstone RW,Frew AJ,Smyth MJ.The TRAIL apoptotic pathway in cancer onset,progression and therapy[J].Nat Rev Cancer,2008,8(10):782-798.
[11]
Jonsson G,Paulie S,Grandien A.High level of cFLIP correlates with resistance to death receptor-induced apoptosis in bladder carcinoma cells[J].Anticancer Res,2003,23(2B):1 213-1 218.
